FK506 may suppress liver injury during the early period following living-related liver transplantation.
Kato
T
T
Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Sato
Y
Y
Kurasaki
I
I
Yamamoto
S
S
Hirano
K
K
Nakatsuka
H
H
Kobayashi
T
T
Kameyama
H
H
Watanabe
T
T
Hatakeyama
K
K
D005190:Family; D006498:Hepatectomy / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008099:Liver / Q000293:injuries / Q000473:pathology*; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D019520:Living Donors / Q000706:statistics & numerical data; D011183:Postoperative Complications / Q000517:prevention & control*; D016559:Tacrolimus / Q000627:therapeutic use*; D020858:Tissue and Organ Harvesting / Q000379:methods
D007166:Immunosuppressive Agents; D016559:Tacrolimus